Catalyst Wire Dossier Catalyst Wire Dossier

Dipyridamole (Asasantin ER)

dipyridamole · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dipyridamole (Asasantin ER), covering 2014-10-24 to 2014-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female Volunteers [Phase 1]

See pricing